Biogens

Business

Biogen’s Japanese partner calls for global action on Alzheimer’s

The recent US approval of Biogen’s Alzheimer’s drug highlights the urgent need for a framework for testing and treating a…

Read More »
Health

Biogen’s debated Alzheimer’s drug given to first patient

A Rhode Island man became the first patient worldwide to receive Biogen’s hotly debated Alzheimer’s drug outside of a clinical…

Read More »
Enterprenuers

Patient receives first infusion of Biogen’s controversial Alzheimer’s drug

The exterior of the headquarters of biotechnology company Biogen in Cambridge, MA is pictured on March 21, 2019. John Tlumacki…

Read More »
Enterprenuers

Third member of prestigious FDA panel resigns over approval of Biogen’s Alzheimer’s drug

A sign for the Food and Drug Administration is seen outside of the headquarters on July 20, 2020 in White…

Read More »
Enterprenuers

Biogen’s new Alzheimer’s drug could cost Medicare billions of dollars a year, report finds

A pedestrian walks past Biogen Inc. headquarters in Cambridge, Massachusetts, on Monday, June 7, 2021. Adam Glanzman | Bloomberg |…

Read More »
Health

FDA OK’s Biogen’s Alzheimer’s drug: What is Accelerated Approval?

The Food and Drug Administration on Monday approved Biogen’s Alzheimer’s drug albeit to mixed reviews. In announcing its decision, the…

Read More »
Health

FDA approval of Biogen’s Alzheimer’s drug leaves some ‘disappointed’

WASHINGTON – Government health officials on Monday approved the first new drug for Alzheimer’s disease in nearly 20 years, disregarding…

Read More »
Enterprenuers

FDA approves Biogen’s Alzheimer’s drug, the first new therapy for the disease in nearly two decades

The Food and Drug Administration on Monday approved Biogen‘s Alzheimer’s drug aducanumab, making it the first drug cleared by U.S.…

Read More »
Stock Market

Will Biogen’s Alzheimer’s Drug Get the FDA’s Nod of Approval? Analyst Weighs In

So far, Alzheimer’s disease is one puzzle the medical community has been unable to solve, and there are currently no…

Read More »
Stock Market

Fate of Biogen’s Stock Rides on Alzheimer’s Drug Decision

(Bloomberg) — For Biogen Inc., the Food and Drug Administration’s expected decision Monday on its Alzheimer’s drug is what a…

Read More »
Back to top button
Close